Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) reports Q2 EPS of $0.60 vs. consensus of $0.32 (NOTE - only 1 analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE